"These new guidelines provide further evidence that the international clinical community sees the value of advanced molecular diagnostics in helping make more informed, individualized breast cancer treatment decisions," said Dr. Joseph Gligorov, Tenon Hospital, Paris.
'Around 70% of all breast cancer patients with stage 1 or II disease could stay free of metastases without any adjuvant therapy. 'It's important to identify this group accurately,' said Dr Joseph Gligorov, oncologist at Tenon Hospital, Paris, who estimated that cutting out unnecessary treatment would improve quality of life and save ?50,000 per patient.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.